Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.55
Delayed Data
As of Jun 22
 +0.1199 / +4.93%
Today’s Change
2.00
Today|||52-Week Range
5.18
+6.25%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close2.43
Today’s open2.42
Day’s range2.42 - 2.59
Volume92,921
Average volume (3 months)90,747
Market cap$31.1M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+66.73%
Earnings growth (this year)+30.65%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+3.70%
P/E ratioNM
Price/Sales0.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc+0.26+2.71%
CDMOPAvid Bioservices Inc-0.25-0.99%
TCONTRACON Pharmaceutica...+0.10+3.64%
AMPEAmpio Pharmaceutical...+0.50+30.12%
Data as of 8:00pm ET, 06/22/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$146.1M
Annual profit (last year)-$77.1M
Net profit margin-52.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
Senior VP, Chief Financial &
Business Officer
Angus W. Smith
Corporate headquarters
Morristown, New Jersey

Forecasts